Mimedx (MDXG) Notes Payables (2010 - 2011)
Mimedx's (MDXG) quarterly Notes Payables came in at $1.3 million in Q4 2011, up 221.24% year-on-year from $403432.0 in Q4 2010, and up 24.44% quarter-over-quarter from $1.0 million in Q3 2011.
Mimedx (MDXG) Notes Payables (2010 - 2011) Analysis & Trends
Mimedx has disclosed Notes Payables across 2 years of filings, most recently posting $1.3 million for Q4 2011.
- Notes Payables for Q4 2011 came in at $1.3 million, up 221.24% year-over-year; the trailing twelve-month figure through Dec 2011 was $1.3 million (up 221.24% YoY), and the FY2011 annual result was $1.3 million, up 221.24% from the prior year.
- Notes Payables came in at $1.3 million for Q4 2011 at Mimedx, up from $1.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2011 to a low of $45540.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.04 Mn |
| Jun 30, 2011 | 45,540.00 |
| Dec 31, 2010 | 403,432.00 |